Referral patterns of patients with liver metastases due to colorectal cancer for resection

被引:3
作者
Al-Sahaf, O. [1 ]
Al-Azawi, Dhafir [2 ]
Al-Khudairy, Ammar [1 ]
Fauzi, Mohammad Z. [1 ]
El-Masry, Sherif [1 ]
Gilen, Peter [1 ]
机构
[1] Our Lady Lourdes Hosp, Dept Gen Surg, Drogheda, Louth, Ireland
[2] Royal Coll Surgeons Ireland, Dublin 2, Ireland
关键词
Colorectal cancer; Liver metastases; Referral for hepatic resection; HEPATIC RESECTION; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; CARCINOMA; SURVIVAL; MANAGEMENT; RECURRENCE; SELECTION;
D O I
10.1007/s00384-008-0561-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction Colorectal carcinoma accounts for 10% of cancer deaths in the Western World, with the liver being the most common site of distant metastases. Resection of liver metastases is the treatment of choice, with a 5-year survival rate of 35%. However, only 5-10% of patients are suitable for resection at presentation. Aims To examine the referral pattern of patients with liver metastases to a specialist hepatic unit for resection. Methodology Retrospective review of patient's charts diagnosed with colorectal liver metastases over a 10-year period. Results One hundred nine (38 women, 71 men) patients with liver metastases were included, mean age 61 years; 79 and 30 patients had synchronous and metachronus metastases, respectively. Ten criteria for referral were identified; the referral rate was 8.25%, with a resection rate of 0.9%. Forty two percent of the patients had palliative chemotherapy; 42% had symptomatic treatment. Conclusion This study highlights the advanced stage of colorectal cancer at presentation; in light of modern evidence-based, centre-oriented therapy of liver metastasis, we conclude that criteria of referral for resection should be based on the availability of treatment modalities.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 26 条
[1]   Improving resectability of hepatic colorectal metastases: Expert consensus statement [J].
Abdalla, Eddie K. ;
Adam, Rene ;
Bilchik, Anton J. ;
Jaeck, Daniel ;
Vauthey, Jean-Nicolas ;
Mahvi, David .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (10) :1271-1280
[2]  
Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
[3]   Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study [J].
Alberts, SR ;
Horvath, WL ;
Stcrnfeld, WC ;
Goldberg, RM ;
Mahoney, MR ;
Dakhil, SR ;
Levitt, R ;
Rowland, K ;
Nair, S ;
Sargent, DJ ;
Donohue, JH .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9243-9249
[4]  
BALLANTYNE GH, 1993, CANCER, V71, P4252, DOI 10.1002/1097-0142(19930615)71:12+<4252::AID-CNCR2820711815>3.0.CO
[5]  
2-6
[6]   Trends in long-term survival following liver resection for hepatic colorectal metastases [J].
Choti, MA ;
Sitzmann, JV ;
Tiburi, MF ;
Sumetchotimetha, W ;
Rangsin, R ;
Schulick, RD ;
Lillemoe, KD ;
Yeo, CJ ;
Cameron, JL .
ANNALS OF SURGERY, 2002, 235 (06) :759-765
[7]   Review article: multimodality treatment of liver metastases increases suitability for surgical treatment [J].
De Jong, K. P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 :161-169
[8]  
FAIVRE J, 1992, TRAITEMENTS METASTAS, P2
[9]   Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET) [J].
Fernandez, FG ;
Drebin, JA ;
Linehan, DC ;
Dehdashti, F ;
Siegel, BA ;
Strasberg, SM .
ANNALS OF SURGERY, 2004, 240 (03) :438-447
[10]   Liver resection for colorectal metastases [J].
Fong, YM ;
Cohen, AM ;
Fortner, JG ;
Enker, WE ;
Turnbull, AD ;
Coit, DG ;
Marrero, AM ;
Prasad, M ;
Blumgart, LH ;
Brennan, MF .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :938-946